These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 29621546)
21. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Yamazaki K; Masugi Y; Effendi K; Tsujikawa H; Hiraoka N; Kitago M; Shinoda M; Itano O; Tanabe M; Kitagawa Y; Sakamoto M Lab Invest; 2014 Jun; 94(6):683-91. PubMed ID: 24709776 [TBL] [Abstract][Full Text] [Related]
22. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling. Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775 [TBL] [Abstract][Full Text] [Related]
23. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323 [TBL] [Abstract][Full Text] [Related]
24. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475 [TBL] [Abstract][Full Text] [Related]
25. ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126. Zhang J; Chen C; Geng Q; Li H; Wu M; Chan B; Wang S; Sheng W J Cell Physiol; 2024 Jun; 239(6):e31259. PubMed ID: 38515383 [TBL] [Abstract][Full Text] [Related]
26. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081 [TBL] [Abstract][Full Text] [Related]
27. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299 [TBL] [Abstract][Full Text] [Related]
28. Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Rückert F; Hennig M; Petraki CD; Wehrum D; Distler M; Denz A; Schröder M; Dawelbait G; Kalthoff H; Saeger HD; Diamandis EP; Pilarsky C; Grützmann R Br J Cancer; 2008 Nov; 99(9):1484-92. PubMed ID: 18854834 [TBL] [Abstract][Full Text] [Related]
29. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
30. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798 [TBL] [Abstract][Full Text] [Related]
31. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling. Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875 [TBL] [Abstract][Full Text] [Related]
32. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer. Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431 [TBL] [Abstract][Full Text] [Related]
33. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590 [TBL] [Abstract][Full Text] [Related]
35. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346 [TBL] [Abstract][Full Text] [Related]
36. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Zhang Y; Zoltan M; Riquelme E; Xu H; Sahin I; Castro-Pando S; Montiel MF; Chang K; Jiang Z; Ling J; Gupta S; Horne W; Pruski M; Wang H; Sun SC; Lozano G; Chiao P; Maitra A; Leach SD; Kolls JK; Vilar E; Wang TC; Bailey JM; McAllister F Gastroenterology; 2018 Jul; 155(1):210-223.e3. PubMed ID: 29604293 [TBL] [Abstract][Full Text] [Related]
37. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. Zhang S; Chung WC; Xu K Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302 [TBL] [Abstract][Full Text] [Related]
38. The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma. Suzuki R; Okubo Y; Takagi T; Sugimoto M; Sato Y; Irie H; Nakamura J; Takasumi M; Kato T; Hashimoto M; Kobashi R; Hikichi T; Ohira H Anticancer Res; 2022 Mar; 42(3):1207-1215. PubMed ID: 35220210 [TBL] [Abstract][Full Text] [Related]
39. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Alonso-Nocelo M; Ruiz-Cañas L; Sancho P; Görgülü K; Alcalá S; Pedrero C; Vallespinos M; López-Gil JC; Ochando M; García-García E; David Trabulo SM; Martinelli P; Sánchez-Tomero P; Sánchez-Palomo C; Gonzalez-Santamaría P; Yuste L; Wörmann SM; Kabacaoğlu D; Earl J; Martin A; Salvador F; Valle S; Martin-Hijano L; Carrato A; Erkan M; García-Bermejo L; Hermann PC; Algül H; Moreno-Bueno G; Heeschen C; Portillo F; Cano A; Sainz B Gut; 2023 Feb; 72(2):345-359. PubMed ID: 35428659 [TBL] [Abstract][Full Text] [Related]
40. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma. Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]